U.S. Expects 1 Million Doses of Covid Antibody Before 2021 (1)

The U.S. has already secured hundreds of thousands of doses of experimental antibody treatments for Covid-19 in anticipation of regulators authorizing their emergency use, federal health officials said on Friday.

The government expects to have 1 million doses of the so-called monoclonal antibody treatments on hand before year-end.

The treatments have come into the spotlight after President Donald Trump received one such experimental therapy last week for his case of Covid-19.

Eli Lilly & Co. and Regeneron Pharmaceuticals Inc. this week asked the U.S. Food and Drug Administration for emergency-use authorizations for their antibody therapies but haven’t yet received ...